Teledyne Technologies Incorporated (NYSE:TDY), a global leader in advanced imaging and sensor solutions, is pleased to announce the start of production on multiple awards to deliver state-of-the-art ...
Baseline Therapeutics, Inc. (“Baseline”), a clinical-stage biotechnology company developing addiction therapeutics, today announced the launch of the company to advance a new generation of ...
John Dorer is CEO of New York City-based EB3.work, a staffing consultancy that helps employers fill positions when they can’t hire locally. Opinions are the author’s own. The labor shortage in the ...
Daiichi Sankyo and Merck & Co.’s phase 3 program for their investigational antibody-drug conjugate has been hit with a hold after an unexpected number of deaths were reported in the global trial. “Due ...
The UK is prepared to cancel its £6.3 billion ($8.4 billion) Ajax program, Defence Secretary John Healey said, after the army halted its use of the armored vehicles built by General Dynamics UK Ltd ...
Islam Makhachev doesn’t think all UFC fighters need to enroll in the “2-3 years Dagestan” project. Makhachev’s advice to Daniel Cormier to send his kids to “Dagestan 2-3 years and forget” has become a ...
BRISTOL, Tenn. (WJHL) – King University held an agreement signing on Tuesday with the Appalachian College of Pharmacy to unveil a new “3+3” accelerated pharmacy program. The program allows students to ...
OAKWOOD, Va. (WVVA) - In a move set to fast-track careers in pharmacy, the Appalachian College of Pharmacy (ACP) and King University today signed a dual degree agreement. It will allow students to ...
Vorolanib in DURAVYU inhibits IL-6-mediated inflammation by blocking JAK receptors, showing sustained improvements in the phase 2 VERONA trial. The phase 3 program includes two non-inferiority trials, ...
The city of Kyle is requesting feedback on its ride-hailing program. (Courtesy Adobe Stock) The city of Kyle wants to hear from its residents about the best ways to provide ride-hailing services to ...
Michael Ingram is a Senior Contributor from the United States of America. Michael has been writing for GameRant since 2021, writing both analytically and fiction for years beforehand. Michael is a ...